ACE2 and COVID-19: Severe COVID-19, which is associated with high levels of inflammatory cytokines (IL-1β and type I and type III interferons), upregulates ACE2 expression, which has the potential to increase target cell availability and, thus, viral replication (131, 134, 139, 142).